SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride (SyB L-0501)
[ 2008/08/18 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200848.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. KAKEN PHARMACEUTICAL CO. and ELITRA PHAR...
Kaken Pharmaceutical Co.,Ltd. 2003/02/20
2. SymBio Pharmaceuticals and Eisai Sign Li...
Eisai Co., Ltd. 2008/08/18
3. Proton Pump Inhibitor ACIPHEX® 20 m...
Eisai Co., Ltd. 2008/07/01
4. Proton Pump Inhibitor ACIPHEX 20 mg Rece...
Eisai Co., Ltd. 2008/07/01
5. Notification of the Completion of Subjec...
R-Tech Ueno, Ltd. 2009/08/25

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. FDA ADVISORY COMMITTEE VOTES IN FAVOR OF...
2008/05/08

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us